---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-010889"
form_type: "8-K"
ticker: "CATX"
cik: "0000728387"
company_name: "Perspective Therapeutics, Inc."
filed_at: "2024-04-03T23:59:59+00:00"
generated_at: "2026-06-04T03:04:31.974373+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Perspective Therapeutics extends asset purchase closing deadline to April 30, 2024

## Summary
- Amendment No. 1 changes the Termination Date under the Asset Purchase Agreement from March 31, 2024 to April 30, 2024.
- Agreement is with GT Medical Technologies for sale of assets by Isoray Medical, a wholly owned subsidiary of Perspective Therapeutics.
- No other terms of the original December 7, 2023 Asset Purchase Agreement were modified.

## SEC filing metadata
- accession: 0001437749-24-010889
- form_type: 8-K
- ticker: CATX
- cik: 0000728387
- company_name: Perspective Therapeutics, Inc.
- filed_at: 2024-04-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/728387/000143774924010889/0001437749-24-010889-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/728387/000143774924010889/isr20240403_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-010889
- JSON: https://secwatch.observer/filing/0001437749-24-010889.json
- Plain text: https://secwatch.observer/filing/0001437749-24-010889.txt

## Key facts
- Material Agreements
  Perspective Therapeutics, Inc. amended Amendment No. 1 to Asset Purchase Agreement with GT Medical Technologies, Inc. valued at Termination date extended from March 31, 2024 to April 30, 2024 (effective 2024-03-28).
  - Action: amendment
  - Agreement: asset purchase
  - Counterparty: GT Medical Technologies, Inc.
  - Value: Termination date extended from March 31, 2024 to April 30, 2024
  - Effective: 2024-03-28
  source text: On March 28, 2024, Perspective Therapeutics, Inc. (the “ Company ”), Isoray Medical, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ Medical ”), and GT Medical Technologies, Inc., a Delaware corporation (“ GT Medical ”) entered into Amendment No. 1 to Asset Purchase Agreement (the “ Amendment ”), which amends the Asset Purchase Agreement entered into by and among the parties on December 7, 2023 (the “ Agreement ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/728387/000143774924010889/0001437749-24-010889-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.